These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 25348370)

  • 41. Comparison of Dosimetric Parameters in Dysphagia Aspiration-Related Structures and Clinical Correlation in Head and Neck Cancer Patients Treated With Radiotherapy.
    Upadhyay P; Kumar P; Chauhan AK; Kumar P; Nigam J; S N
    Cureus; 2022 Jul; 14(7):e26765. PubMed ID: 35967135
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Investigation of the Effect of Radiotherapy Dose on Chewing and Swallowing Structures in Head and Neck Cancer Patients Treated with Concomitant Chemoradiotherapy.
    Baştuğ Dumbak A; Esen Aydınlı F; Yazıcı G; İncebay Ö; Yıldız Z; Yüce D; Süslü N; Kuşçu O; Kulak Kayıkcı ME
    Dysphagia; 2022 Dec; 37(6):1400-1413. PubMed ID: 35075541
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Whole-Field Sequential Intensity-Modulated Radiotherapy for Local-Regional Advanced Head-and-Neck Squamous Cell Carcinoma.
    Refaat T; Choi M; Thomas TO; Bacchus I; Agulnik M; Pelzer HJ; Mellott AL; Rademaker AW; Liu D; Sathiaseelan V; Mittal BB
    Am J Clin Oncol; 2015 Dec; 38(6):588-94. PubMed ID: 24136140
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Organ sparing and clinical outcome with step-and-shoot IMRT for head and neck cancer: a mono-institutional experience.
    Mazzola R; Ferrera G; Alongi F; Mannino M; Abbate B; Cucchiara T; Iacoviello G; Sciumè F; Di Paola G; Federico M; Blasi L; Lo Casto A; Lagalla R; Messana D
    Radiol Med; 2015 Aug; 120(8):753-8. PubMed ID: 25663551
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Feasibility of Achieving Dose Constraints for Dysphagia Aspiration-Related Structures and Its Clinical Significance in Intensity-Modulated Radiotherapy Planning of Head and Neck Cancer.
    Agarwal K; Kumar P; S N; Kumar P; Garg A; Nigam J; N S S
    Cureus; 2024 Feb; 16(2):e53769. PubMed ID: 38465172
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlating computed tomography perfusion changes in the pharyngeal constrictor muscles during head-and-neck radiotherapy to dysphagia outcome.
    Truong MT; Lee R; Saito N; Qureshi MM; Ozonoff A; Romesser PB; Wang J; Sakai O
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e119-27. PubMed ID: 21669502
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Magnetic resonance imaging of swallowing-related structures in nasopharyngeal carcinoma patients receiving IMRT: Longitudinal dose-response characterization of quantitative signal kinetics.
    Messer JA; Mohamed AS; Hutcheson KA; Ding Y; Lewin JS; Wang J; Lai SY; Frank SJ; Garden AS; Sandulache V; Eichelberger H; French CC; Colen RR; Phan J; Kalpathy-Cramer J; Hazle JD; Rosenthal DI; Gunn GB; Fuller CD
    Radiother Oncol; 2016 Feb; 118(2):315-22. PubMed ID: 26830697
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictors of toxicity after curative reirradiation with intensity modulated radiotherapy or proton therapy for recurrent head and neck carcinoma: new dose constraints for pharyngeal constrictors muscles and oral cavity.
    Beddok A; Maynadier X; Krhili S; Ala Eddine C; Champion L; Chilles A; Goudjil F; Zefkili S; Amessis M; Choussy O; Le Tourneau C; Buvat I; Créhange G; Carton M; Calugaru V
    Strahlenther Onkol; 2023 Oct; 199(10):901-909. PubMed ID: 37256301
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Toxicity profile and early clinical outcome for advanced head and neck cancer patients treated with simultaneous integrated boost and volumetric modulated arc therapy.
    Franzese C; Fogliata A; Clerici E; Franceschini D; Villa E; D'Agostino G; Navarria P; Mancosu P; Tomatis S; Cozzi L; Scorsetti M
    Radiat Oncol; 2015 Nov; 10():224. PubMed ID: 26545871
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dose to the inferior pharyngeal constrictor predicts prolonged gastrostomy tube dependence with concurrent intensity-modulated radiation therapy and chemotherapy for locally-advanced head and neck cancer.
    Vlacich G; Spratt DE; Diaz R; Phillips JG; Crass J; Li CI; Shyr Y; Cmelak AJ
    Radiother Oncol; 2014 Mar; 110(3):435-40. PubMed ID: 24440043
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dysphagia and trismus after concomitant chemo-Intensity-Modulated Radiation Therapy (chemo-IMRT) in advanced head and neck cancer; dose-effect relationships for swallowing and mastication structures.
    van der Molen L; Heemsbergen WD; de Jong R; van Rossum MA; Smeele LE; Rasch CR; Hilgers FJ
    Radiother Oncol; 2013 Mar; 106(3):364-9. PubMed ID: 23540551
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: A planning comparative study.
    van der Laan HP; van de Water TA; van Herpt HE; Christianen ME; Bijl HP; Korevaar EW; Rasch CR; van 't Veld AA; van der Schaaf A; Schilstra C; Langendijk JA;
    Acta Oncol; 2013 Apr; 52(3):561-9. PubMed ID: 22708528
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dose intensified hypofractionated intensity-modulated radiotherapy with synchronous cetuximab for intermediate stage head and neck squamous cell carcinoma.
    Thomson DJ; Ho KF; Ashcroft L; Denton K; Betts G; Mais KL; Garcez K; Yap BK; Lee LW; Sykes AJ; Rowbottom CG; Slevin NJ
    Acta Oncol; 2015 Jan; 54(1):88-98. PubMed ID: 25279959
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IMRT using simultaneously integrated boost (SIB) in head and neck cancer patients.
    Studer G; Huguenin PU; Davis JB; Kunz G; Lütolf UM; Glanzmann C
    Radiat Oncol; 2006 Mar; 1():7. PubMed ID: 16722599
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Persistent dysphagia after head and neck radiotherapy: a common and under-reported complication with significant effect on non-cancer-related mortality.
    Szczesniak MM; Maclean J; Zhang T; Graham PH; Cook IJ
    Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):697-703. PubMed ID: 25239671
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thyroid V50 Highly Predictive of Hypothyroidism in Head-and-Neck Cancer Patients Treated With Intensity-modulated Radiotherapy (IMRT).
    Sachdev S; Refaat T; Bacchus ID; Sathiaseelan V; Mittal BB
    Am J Clin Oncol; 2017 Aug; 40(4):413-417. PubMed ID: 25503434
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patterns of dysphagia and acute toxicities in patients with head and neck cancer undergoing helical IMRT±concurrent chemotherapy.
    Moroney LB; Helios J; Ward EC; Crombie J; Wockner LF; Burns CL; Spurgin AL; Blake C; Kenny L; Hughes BG
    Oral Oncol; 2017 Jan; 64():1-8. PubMed ID: 28024718
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Radiation-induced long-term dysphagia in survivors of head and neck cancer and association with dose-volume parameters.
    Huynh TM; Dale E; Falk RS; Hellebust TP; Astrup GL; Malinen E; Edin NFJ; Bjordal K; Herlofson BB; Kiserud CE; Helland Å; Amdal CD
    Radiother Oncol; 2024 Jan; 190():110044. PubMed ID: 38061420
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identifying organs at risk for radiation-induced late dysphagia in head and neck cancer patients.
    Hedström J; Tuomi L; Finizia C; Olsson C
    Clin Transl Radiat Oncol; 2019 Nov; 19():87-95. PubMed ID: 31646203
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Volumetric changes in pharyngeal structures following head and neck cancer chemoradiation therapy.
    Hinther A; Samson N; Lau H; Quon H; Banerjee R; Lysack JT; Grendarova P; Matthews TW; Randall DR
    Laryngoscope; 2020 Mar; 130(3):597-602. PubMed ID: 31260128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.